Skip to main content

Highlights

  1. 1
    Methods in cell biology · 2023
    PMID: 37890935DOIFirst author2 citations

Publications

37 publications

Funding

8 grants

Active

7 grants
  • Co-I
    Systemic Theranostic 203Pb/212Pb Alpha-Radioimmunotherapy for Advanced Colorectal Cancer
    National Cancer Institute · 2026–2031
    R01CA317908-01
  • Co-I
    Quantitative cerebral oxygen metabolic imaging of acute ischemic stroke
    National Institute of Neurological Disorders and Stroke · 2024–2029
    R01NS135205-01A1
  • Co-I
    Theranostic Trop-2-directed pretargeted radioimmunotherapy for metastatic prostate cancer with curative intent
    U.S. Department of Defense · 2025–2028
    HT9425-25-1-0152
  • KP
    Modernization and Expansion of the Citigroup Biomedical Imaging Center at Weill Cornell Medical College
    Office of the Director, NIH · 2023–2027
    C06OD036045-01
  • Co-I
    An engineered bacterial reporter gene fusion for radiotheranostics
    National Cancer Institute · 2024–2027
    R21CA287211-01A1
  • Co-I
    Development and optimization of CEACAM5-targeted alpha emitters
    Prostate Cancer Foundation · 2025–2027
    24CHAL11
  • KP
    New PET/CT System for Human and Non-human Primate Imaging
    Office of the Director, NIH · 2023–2026
    S10OD034271-01
Completed grants (1)
  • Co-I
    DOTA-based pre-targeting of alpha emitters
    National Cancer Institute · 2018–2024· 2 renewals
    R01CA233896-05